46 results
PRE 14A
VRNA
Verona Pharma Plc
8 Mar 24
Preliminary proxy
4:18pm
(as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material under § 240.14a-12
VERONA PHARMA PLC … (Check all boxes that apply):
No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b
8-K
EX-10.1
bjjtf491g7 ga
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
8-K
1e8407bx yie
20 Dec 22
Regulation FD Disclosure
6:02am
8-K
EX-10.1
tanerrgrp n9pbg8uow
17 Oct 22
Entry into a Material Definitive Agreement
6:00am
8-K
EX-1.1
9xqe6inc7kkhn jn
11 Aug 22
Other Events
5:46pm
424B5
6vug6l5ezfk
11 Aug 22
Prospectus supplement for primary offering
5:09pm
8-K
ftsrs23uazk8 7j41pe
9 Aug 22
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:17am
424B5
r3tb eu21i2i
9 Aug 22
Prospectus supplement for primary offering
12:00am